1. Home
  2. CNTA vs CMRE Comparison

CNTA vs CMRE Comparison

Compare CNTA & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • CMRE
  • Stock Information
  • Founded
  • CNTA 2020
  • CMRE 1974
  • Country
  • CNTA United Kingdom
  • CMRE Monaco
  • Employees
  • CNTA N/A
  • CMRE N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • CMRE Marine Transportation
  • Sector
  • CNTA Health Care
  • CMRE Consumer Discretionary
  • Exchange
  • CNTA Nasdaq
  • CMRE Nasdaq
  • Market Cap
  • CNTA 2.0B
  • CMRE 1.9B
  • IPO Year
  • CNTA 2021
  • CMRE 2010
  • Fundamental
  • Price
  • CNTA $15.67
  • CMRE $13.74
  • Analyst Decision
  • CNTA Strong Buy
  • CMRE Hold
  • Analyst Count
  • CNTA 7
  • CMRE 2
  • Target Price
  • CNTA $23.14
  • CMRE $13.50
  • AVG Volume (30 Days)
  • CNTA 271.8K
  • CMRE 304.4K
  • Earning Date
  • CNTA 11-15-2024
  • CMRE 11-01-2024
  • Dividend Yield
  • CNTA N/A
  • CMRE 3.34%
  • EPS Growth
  • CNTA N/A
  • CMRE N/A
  • EPS
  • CNTA N/A
  • CMRE 3.01
  • Revenue
  • CNTA $6,853,000.00
  • CMRE $2,030,338,000.00
  • Revenue This Year
  • CNTA N/A
  • CMRE $6.79
  • Revenue Next Year
  • CNTA N/A
  • CMRE N/A
  • P/E Ratio
  • CNTA N/A
  • CMRE $4.52
  • Revenue Growth
  • CNTA N/A
  • CMRE 58.37
  • 52 Week Low
  • CNTA $5.58
  • CMRE $8.61
  • 52 Week High
  • CNTA $17.59
  • CMRE $17.58
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 52.05
  • CMRE 45.74
  • Support Level
  • CNTA $14.48
  • CMRE $13.08
  • Resistance Level
  • CNTA $15.64
  • CMRE $13.95
  • Average True Range (ATR)
  • CNTA 0.67
  • CMRE 0.41
  • MACD
  • CNTA -0.11
  • CMRE -0.06
  • Stochastic Oscillator
  • CNTA 55.87
  • CMRE 45.52

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

Share on Social Networks: